Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes

Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes

Lung cancer is the leading cause of cancer-related deaths globally, accounting for 1.8 million fatalities in 2020. Genetic mutations, chromosomal abnormalities, transcription factors, mutations in tumor suppressor genes, and mutations in oncogenes have all been associated with an increased risk of L...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saloni Mangal, Abhijit Debnath, Rupa Mazumder, Avijit Mazumder, Rajesh Kumar Singh, Jahanvi Sanchitra, S.K. Asif Jan, Pratibha Pandey, Bimlesh Kumar, Anil Kumar Singh
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	All Life
Subjects:	lung cancer lung cancer drug targets small cell carcinoma non-small cell carcinoma lung cancer drugs
Online Access:	http://dx.doi.org/10.1080/26895293.2024.2417192
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnosis of lung cancer using salivary miRNAs expression and clinical characteristics
by: Negar Alizadeh, et al.
Published: (2025-01-01)

Association of whole grain food consumption with lung cancer risk: a prospective cohort study
by: Kanran Wang, et al.
Published: (2025-01-01)

Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy
by: Shuai Wang, et al.
Published: (2025-02-01)

Klinefelter syndrome diagnosed at autopsy and small-cell lung carcinoma
by: Haruyasu Sakuranaka, et al.
Published: (2025-01-01)

Remarkable response to low dose of selpercatinib in a patient with RET-rearranged non-small cell lung cancer
by: Jun Sakakibara-Konishi, et al.
Published: (2025-01-01)

PAX6 enhances Nanog expression by inhibiting NOTCH signaling to promote malignant properties in small cell lung cancer cells
by: Xiao-Fang Guo, et al.
Published: (2025-01-01)

A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy
by: Nao Kobayashi, et al.
Published: (2025-01-01)

Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling
by: David Peeney, et al.
Published: (2025-03-01)

Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
by: Liu Rui, et al.
Published: (2023-06-01)

PARP inhibitors as therapy for small cell lung carcinoma: A systematic review and meta-analysis of clinical trials
by: Samuel Pratama, et al.
Published: (2024-01-01)

LncRNA MANCR is downregulated in non-small cell lung cancer and predicts poor survival
by: Yunming Tao, et al.
Published: (2025-01-01)

Predictive Value of Initial 18F-FDG PET/CT for Identifying EGFR and KRAS Mutations in Patients with Non-small-cell Lung Cancer
by: Ozge Vural Topuz, et al.
Published: (2024-11-01)

Development and validation of a predictive model for lymph node metastases in peripheral non-small cell lung cancer with a tumor diameter ≤ 2.0 cm and a consolidation-to-tumor ratio > 0.5
by: Dongyu Li, et al.
Published: (2025-01-01)

Experimental approach to obtaining subcutaneous xenograft of non-small cell lung cancer
by: E. A. Lukbanova, et al.
Published: (2022-06-01)

Canine lung carcinoma—A descriptive review
by: Aleksandra Marcinowska, et al.
Published: (2025-01-01)

Impact of DLL3 Expression as Prognostic Factor in Extensive Stage of Small Cell Lung Cancer Treated With First‐Line Chemotherapy
by: Hohyung Nam, et al.
Published: (2025-01-01)

Composition of the sputum bacterial microbiome of patients with different pathomorphological forms of non-small-cell lung cancer
by: V. G. Druzhinin, et al.
Published: (2024-04-01)

Survival outcomes of surgery and adjuvant chemotherapy in early-stage small cell and large cell lung cancer: a novel focus on tumors less than 1 cm
by: Jorge Raul Vazquez-Urrutia, et al.
Published: (2025-01-01)

Concordance of Bronchoalveolar Lavage Fluid Cytology with Respect to Histological Diagnosis of Cancer: A Cross-sectional Study
by: Richa Singh, et al.
Published: (2025-01-01)

Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
by: Yugo Matsumura, et al.
Published: (2025-01-01)

The Treatment Effect of Plantago Major on Lung Cancer Based on the Computed Tomography and Pathological Findings: A Case Report Study
by: Saade Abdalkareem Jasim, et al.
Published: (2025-01-01)

Sinonasal small-cell carcinoma combined concurrently with small-cell lung carcinoma: case report and literature review
by: Rencui Quan, et al.
Published: (2025-01-01)

Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs
by: Kawaljit Kaur, et al.
Published: (2025-01-01)

Comparing survival outcomes of localized tumor destruction, sublobar resection, and pulmonary lobectomy in stage IA non-small cell lung cancer: a study from the SEER database
by: Lin Cheng, et al.
Published: (2025-02-01)

Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
by: Jieran Long, et al.
Published: (2024-09-01)

Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review
by: Mingyue Wang, et al.
Published: (2025-02-01)

Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability
by: Huiling Su, et al.
Published: (2025-02-01)

EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis
by: Ao Liu, et al.
Published: (2024-11-01)

Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study
by: Zhi Yang, et al.
Published: (2025-01-01)

The impact of KRAS mutations on the tumour microenvironment and treatment response in non-small cell lung cancer
by: Guomin Gu, et al.
Published: (2024-12-01)

Perioperative or neo/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
by: Qiong Zhang, et al.
Published: (2025-01-01)

Machine learning insights into early mortality risks for small cell lung cancer patients post-chemotherapy
by: Min Liang, et al.
Published: (2025-01-01)

The role of radiotherapy in small cell lung cancer: a new paradigm for the radiation oncologist
by: Paolo Borghetti, et al.
Published: (2025-01-01)

Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog
by: Ting Ye, et al.
Published: (2019-03-01)

TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology
by: Jing Lu, et al.
Published: (2025-03-01)

The Relationship of Sirtuin 1 and Sirtuin 2 Expression with Clinicopathological Parameters in Non Small-Cell Lung Carcinomas
by: Fatma Cakmak Kazanci, et al.
Published: (2024-11-01)

Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study
by: Tongji Xie, et al.
Published: (2024-12-01)

Oxymatrine inhibits the development of radioresistance in NSCLC cells by reversing EMT through the DcR3/AKT/GSK-3β pathway
by: Jianming Tang, et al.
Published: (2023-01-01)

First molecules to reactivate RASG12V GTPase activity
by: Aneta Wlodarczyk, et al.
Published: (2025-01-01)

Pembrolizumab plus Pemetrexed and Platinum in Metastatic Non-Squamous Non-Small Cell Lung Cancer: A Real-Life Study at a Portuguese Centre
by: Maria João Santos, et al.
Published: (2025-02-01)